HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

George P Studzinski Selected Research

Myeloid Leukemia (Leukemia, Myelocytic)

4/20151,25-Dihydroxyvitamin D3 induces monocytic differentiation of human myeloid leukemia cells by regulating C/EBPβ expression through MEF2C.
3/2015The Potential of Vitamin D-Regulated Intracellular Signaling Pathways as Targets for Myeloid Leukemia Therapy.
10/2014ERK 5/MAPK pathway has a major role in 1α,25-(OH)2 vitamin D3-induced terminal differentiation of myeloid leukemia cells.
7/2014ERK5 pathway regulates transcription factors important for monocytic differentiation of human myeloid leukemia cells.
10/2011MicroRNA-32 upregulation by 1,25-dihydroxyvitamin D3 in human myeloid leukemia cells leads to Bim targeting and inhibition of AraC-induced apoptosis.
2/2011The Nrf2 transcription factor is a positive regulator of myeloid differentiation of acute myeloid leukemia cells.
7/2010Expression of MAP3 kinase COT1 is up-regulated by 1,25-dihydroxyvitamin D3 in parallel with activated c-jun during differentiation of human myeloid leukemia cells.
5/2010Vitamin D3-driven signals for myeloid cell differentiation--implications for differentiation therapy.
10/2009c-Jun N-terminal kinase 2 (JNK2) antagonizes the signaling of differentiation by JNK1 in human myeloid leukemia cells resistant to vitamin D.
3/2009MicroRNAs181 regulate the expression of p27Kip1 in human myeloid leukemia cells induced to differentiate by 1,25-dihydroxyvitamin D3.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


George P Studzinski Research Topics

Disease

27Neoplasms (Cancer)
10/2021 - 03/2003
20Leukemia
11/2016 - 05/2002
20Myeloid Leukemia (Leukemia, Myelocytic)
04/2015 - 03/2003
14Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2018 - 10/2005
5Hypercalcemia (Milk Alkali Syndrome)
09/2010 - 05/2002
3Communicable Diseases (Infectious Diseases)
10/2021 - 12/2014
3Infections
10/2021 - 12/2014
2Hepatocellular Carcinoma (Hepatoma)
08/2020 - 01/2020
2Hematologic Neoplasms (Hematological Malignancy)
05/2016 - 08/2015
1Cytokine Release Syndrome
10/2021
1COVID-19
10/2021
1Inflammation (Inflammations)
10/2021
1Lung Diseases (Lung Disease)
10/2021
1Necrosis
11/2016
1Disease Progression
05/2016
1Tuberculosis (Tuberculoses)
01/2016
1Malaria
01/2016
1Bacterial Infections (Bacterial Infection)
12/2014
1Hypersensitivity (Allergy)
12/2014
1Cardiovascular Diseases (Cardiovascular Disease)
12/2014
1Vitamin D Deficiency
12/2014
1Bone Diseases (Bone Disease)
12/2014
1B-Cell Lymphoma (Lymphoma, B Cell)
12/2014
1Carcinoma (Carcinomatosis)
04/2012
1Myelodysplastic Syndromes (Myelodysplastic Syndrome)
05/2010
1Osteosarcoma (Osteogenic Sarcoma)
01/2009
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2009

Drug/Important Bio-Agent (IBA)

27Vitamin DFDA LinkGeneric
10/2021 - 03/2003
16Calcitriol (Calcijex)FDA LinkGeneric
04/2015 - 05/2002
121,25-dihydroxyvitamin DIBA
10/2011 - 08/2003
10salvinIBA
08/2020 - 03/2003
6PolyphenolsIBA
01/2018 - 06/2006
5AntioxidantsIBA
11/2016 - 03/2003
4Cholecalciferol (Vitamin D3)FDA Link
10/2014 - 05/2002
4Phosphotransferases (Kinase)IBA
10/2014 - 08/2004
4Transcription Factors (Transcription Factor)IBA
07/2014 - 08/2003
3CalciumIBA
04/2012 - 03/2003
2Sorafenib (BAY 43-9006)FDA Link
08/2020 - 01/2020
2Ergocalciferols (Ergocalciferol)FDA LinkGeneric
01/2020 - 01/2018
2Therapeutic UsesIBA
01/2018 - 08/2015
2Cytarabine (Cytosar-U)FDA LinkGeneric
01/2018 - 01/2017
21 alpha-hydroxyergocalciferol (doxercalciferol)FDA Link
01/2018 - 01/2012
2CurcuminIBA
05/2016 - 01/2010
2Calcitriol Receptors (Calcitriol Receptor)IBA
12/2014 - 12/2007
2VitaminsIBA
10/2014 - 08/2003
21 alpha,24-dihydroxyvitamin D3 (Tacalcitol)IBA
07/2012 - 10/2005
2Silybin (Lagosa)IBA
11/2010 - 01/2010
2Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
11/2006 - 08/2003
2JNK Mitogen-Activated Protein KinasesIBA
04/2006 - 08/2003
2CCAAT-Enhancer-Binding Protein-betaIBA
10/2005 - 01/2004
1proto-oncogene protein Spi-1IBA
01/2017
1Proteins (Proteins, Gene)FDA Link
11/2016
1Biological ProductsIBA
05/2016
1AntigensIBA
12/2014
1Granzymes (Granzyme)IBA
12/2014
1BIX 02189IBA
10/2014
1hydroxide ionIBA
10/2014
1XMD 8-92IBA
10/2014
1Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
06/2014
1Tyrosine Kinase InhibitorsIBA
06/2014
11,25-dihydroxyergocalciferolIBA
07/2012
1quinoline-val-asp(OMe)-CH2-OPHIBA
07/2012
1CaspasesIBA
07/2012
1Caspase InhibitorsIBA
07/2012
1Oxidants (Oxidizing Agents)IBA
04/2012
1Histones (Histone)IBA
04/2012
1Messenger RNA (mRNA)IBA
10/2011
1Oncogene Proteins (Oncogene Protein)IBA
05/2011
1MAP Kinase Kinase Kinases (MAP Kinase Kinase Kinase)IBA
07/2010
1nutlin 3IBA
05/2010
1Mitogen-Activated Protein Kinase 9IBA
10/2009
1Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA
04/2008
1Salicylic Acid (2 Hydroxybenzoic Acid)FDA LinkGeneric
04/2008
1Indomethacin (Indometacin)FDA LinkGeneric
04/2008
1Pharmaceutical PreparationsIBA
12/2007
1KSR-1 protein kinaseIBA
08/2007
1SteroidsIBA
06/2007
11,25-dihydroxy-16,23-diene vitamin D3IBA
06/2006
1Cyclin-Dependent Kinases (cdk Proteins)IBA
08/2004
1CCAAT-Enhancer-Binding ProteinsIBA
01/2004
1Retinoblastoma ProteinIBA
01/2004
1Hormones (Hormone)IBA
08/2003
1Transcription Factor AP-1 (Transcription Factor AP 1)IBA
08/2003
1Mitogen-Activated Protein KinasesIBA
08/2003
11,25-dihydroxy-5,6-16-ene-vitamin D3IBA
05/2002

Therapy/Procedure

20Therapeutics
01/2020 - 03/2003
5Chemoprevention
01/2009 - 08/2004
3Drug Therapy (Chemotherapy)
01/2017 - 08/2004
1Injections
06/2006